drugset / Trial / NCT04132011
Dosing Intervals of Opioid Medication for Chronic Pain
Phase 4
Withdrawn
University Health Network, Toronto
Canadian Society of Hospital Pharmacists · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
This study is to determine the feasibility of an n-of-1, randomized, double blind, placebo controlled case series to examine effects of extended release opioids when used at intervals shorter than recommended by the manufacturer by people with chronic pain.
Timeline
- Start
- 2019-05-01
- Primary completion
- 2020-03-08
- Completion
- 2020-03-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydromorphone | Other / unclassified | — | — |
| Comparator | Morphine | Other / unclassified | — | — |
| Comparator | Oxycodone | Other / unclassified | — | — |